Imprimis NJOF

Imprimis NJOF is a New Jersey-based operating subsidiary within the ImprimisRx/Harrow organization that functions as an FDA-registered 503B outsourcing facility focused on compounded ophthalmic medications. The business supplies sterile injectable and topical ophthalmic formulations for office and surgical use, including dexamethasone-, moxifloxacin-, ketorolac-, bromfenac-, atropine-, and related eye-care products. It appears to support ImprimisRx’s broader strategy of providing accessible ophthalmic medicines to ophthalmologists and optometrists rather than developing a traditional therapeutic R&D pipeline. The entity is healthcare-related and commercial-stage, with activity centered on manufacturing and distribution of compounded ophthalmic products in the U.S. market. Public disclosures indicate it is a subsidiary of Harrow and remains active.